
    
      Groups:

      Experimental treatment: Metformin-GLP-1 Receptor Agonist Therapy.

      Regular treatment: Metformin-Oral Contraceptive(OC) Therapy.

      Time Point:

      Initial treatment;

      Post-treatment (4w);

      Post-treatment (8w);

      Post-treatment (12w);

      Assess reproductive functions and cardiovascular risk factors.
    
  